Brief: TriSalus Life Sciences Reports Q4 and Full Year 2024 Financial Results and Provides Business Update
March 27 (Reuters) - TriSalus Life Sciences Inc TLSI.O: TRISALUS LIFE SCIENCES Q4 PRETAX PROFIT USD -10.109 MILLION TRISALUS LIFE SCIENCES Q4 REVENUE USD 8.261 MILLION VERSUS. IBES ESTIMATE USD 8.12 MILLION TRISALUS LIFE SCIENCES Q4 INCOME FROM OPERATIONS USD -7.58 MILLION TRISALUS LIFE SCIENCES Q4 BASIC EPS USD -0.4 VERSUS. IBES ESTIMATE USD -0.32 TRISALUS LIFE SCIENCES Q4 GROSS PROFIT USD 7.045 MILLION Source text: ID:nBw2n60nWa Further company coverage: TLSI.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on TriSalus Life Sciences
See all newsTriSalus jumps after FDA clears liver treatment device
Brief: Trisalus Life Sciences Receives FDA Clearance For Trinav Advance
TriSalus Life Sciences Inc reports results for the quarter ended June 30 - Earnings Summary
TriSalus Life Sciences Q2 revenue beats estimates
TriSalus Life Sciences Inc expected to post a loss of 15 cents a share - Earnings Preview